Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Atogepant (Qulipta) for migraine prevention.

< BACK TO ARCHIVE


2021 Nov 01


Med Lett Drugs Ther


http://www.ncbi.nlm.nih.gov/pubmed/35085204?dopt=Abstract


63


1636

Atogepant (Qulipta) for migraine prevention.

Authors

Atogepant (Qulipta) for migraine prevention.
Med Lett Drugs Ther. 2021 Nov 01; 63(1636):169-171.
PMID: 35085204.